Huntsman Announces Strong Fourth Quarter 2017 Results; Net Leverage Reduced to 1.4x; The Board Approves a 30% Dividend Increase and Share Repurchases of up to $450 million
THE WOODLANDS, Texas, Feb. 23, 2018 /PRNewswire/ --
Fourth Quarter 2017 Highlights
- Net income was $287 million compared to $137 million in the prior year period and $179 million in the prior quarter.
- Adjusted EBITDA was $360 million compared to $210 million in the prior year period and $340 million in the prior quarter.
- Diluted income per share was $1.00 compared to $0.53 in the prior year period and $0.60 in the prior quarter.
- Adjusted diluted income per share was $0.76 compared to $0.21 in the prior year period and $0.67 in the prior quarter.
- Net cash provided by operating activities was $304 million. Free cash flow generation was $190 million.
- Successful secondary offering of Venator (NYSE – VNTR) shares was completed in December. The net proceeds were used to pay down the remaining $511 million on Huntsman's Term Loan B due 2023, reducing net leverage to 1.4x. Huntsman's remaining ownership interest in Venator is currently approximately 53%.
Full Year 2017 Highlights
- Net income was $741 million compared to $357 million in the prior year.
- Adjusted EBITDA was $1,259 million compared to $997 million in the prior year.
- Net cash provided by operating activities was $842 million compared to $974 million in the prior year. Free cash flow generation was $594 million compared to free cash flow of $656 million in the prior year.
- Annual free cash flow target for the upcoming years is increased by $50 million to between $450 million and $650 million.
- In 2017, debt was reduced by approximately $2.1 billion and Huntsman exited the year with the strongest balance sheet in its history with a net debt to EBITDA ratio of 1.4x. Since the beginning of 2016 to the end of 2017, net debt was reduced by 60%, from $4.5 billion to $1.8 billion.
- The board approved a 30% increase of the quarterly dividend from $0.125 to $0.1625 per share, effective immediately, and share repurchases up to $450 million.
Three months ended |
Twelve months ended |
|||||||||
December 31, |
September 30, |
December 31, |
||||||||
In millions, except per share amounts |
2017 |
2016 |
2017 |
2017 |
2016 |
|||||
Revenues |
$2,203 |
$1,904 |
$ 2,169 |
$8,358 |
$ 7,518 |
|||||
Net income |
$ 287 |
$ 137 |
$ 179 |
$ 741 |
$ 357 |
|||||
Adjusted net income(1) |
$ 186 |
$ 50 |
$ 164 |
$ 604 |
$ 352 |
|||||
Diluted income per share |
$ 1.00 |
$ 0.53 |
$ 0.60 |
$ 2.61 |
$ 1.36 |
|||||
Adjusted diluted income per share(1) |
$ 0.76 |
$ 0.21 |
$ 0.67 |
$ 2.48 |
$ 1.47 |
|||||
Adjusted EBITDA(1) |
$ 360 |
$ 210 |
$ 340 |
$1,259 |
$ 997 |
|||||
Pro forma adjusted EBITDA(2) |
$ 360 |
$ 204 |
$ 340 |
$1,259 |
$ 969 |
|||||
Net cash provided by operating activities |
$ 304 |
$ 238 |
$ 261 |
$ 842 |
$ 974 |
|||||
Free cash flow(3) |
$ 190 |
$ 133 |
$ 227 |
$ 594 |
$ 656 |
|||||
See end of press release for footnote explanations |
Huntsman Corporation (NYSE: HUN) today reported fourth quarter 2017 results with revenues of $2,203 million, net income of $287 million and adjusted EBITDA of $360 million.
Peter R. Huntsman, Chairman, President and CEO, commented:
"2017 was a transformational year marked with significant milestones for our Company. We successfully separated our Pigments and Additives business, now called Venator, by IPO and completed a first follow-on offering in December. Combined with our cash flow and the $1.7 billion in net proceeds from Venator, we were able to pay down approximately $2.1 billion in debt during the year. This debt reduction enabled Huntsman to enter 2018 with the strongest balance sheet in its history, with a net debt to EBITDA ratio of 1.4x, which is well within investment grade metrics.
"With a stronger balance sheet, our focus will be to continue to invest in our operational reliability and organic growth. We expect to generate between $450 million and $650 million of free cash flow in the upcoming years. We will also pursue acquisitions that will create value, greater growth in our downstream business and stronger earnings. This morning we are enhancing our shareholder returns by increasing the dividend 30% and announcing a share repurchase program of up to $450 million."
Segment Analysis for 4Q17 Compared to 4Q16
Polyurethanes
The increase in revenues in our Polyurethanes segment for the three months ended December 31, 2017 compared to the same period in 2016 was primarily due to higher MDI average selling prices and MDI sales volumes. MDI average selling prices increased due to strong market conditions in all regions. The increase in MDI sales volumes was more than offset by a decrease in MTBE sales volumes resulting from the timing of MTBE shipments. The increase in adjusted EBITDA was primarily due higher MDI margins and sales volumes.
Performance Products
Revenues in our Performance Products segment for the three months ended December 31, 2017 compared to the same period in 2016 were essentially flat as higher average selling prices and improved mix were offset by lower sales volumes. Average selling prices increased primarily in response to higher raw material costs and favorable product mix. The decrease in sales volumes was primarily due to the sale of the European surfactants business to Innospec Inc. in 2016, as well as planned and unplanned outages at our Port Neches site. The decrease in adjusted EBITDA was primarily due to the sale of the European surfactants business and higher costs, which includes the impact of the outages in the quarter, partially mitigated by continued margin improvement in our maleic anhydride business.
Advanced Materials
The increase in revenues in our Advanced Materials segment for the three months ended December 31, 2017, compared to the same period in 2016, was primarily due to higher average sales prices. Average selling prices increased primarily due to sales mix, as sales volumes in our higher value specialty business increased across all of our core markets. This growth in revenues was partially offset by lower sales volumes in our lower value wind and other commodity markets. Adjusted EBITDA increased due to higher specialty sales volumes and lower fixed costs, partially offset by higher raw material costs.
Textile Effects
The increase in revenues in our Textile Effects segment for the three months ended December 31, 2017 compared to the same period in 2016 was primarily due to volume growth, partially offset by lower average selling prices and unfavorable product mix. Sales volumes increased in the Americas, Europe and China. Average selling prices decreased primarily due to lower raw material costs. The increase in adjusted EBITDA was primarily due to higher sales volumes.
Corporate, LIFO and Other
Adjusted EBITDA from Corporate, LIFO and Other decreased by $1 million to a loss of $53 million for the three months ended December 31, 2017 compared to a loss of $52 million for the same period in 2016.
Held for Sale and Discontinued Operations
Our former Pigments and Additives segment, now known as Venator, is now classified as held for sale on our balance sheet and treated as discontinued operations on our income statement. Please refer to the Form 8-K we filed on October 31, 2017 with certain restated historical financial data. Huntsman currently owns 53% of Venator's outstanding shares.
Liquidity, Capital Resources and Outstanding Debt
During the fourth quarter of 2017, we generated adjusted free cash flow of $190 million compared to $133 for the same period 2016. As of December 31, 2017, we had $1,247 million of combined cash and unused borrowing capacity compared to $1,208 million as of December 31, 2016. For the full year 2017, including the approximate $1.7 billion debt repayment made with the proceeds of the Venator separation, we repaid approximately $2.1 billion of debt. In connection with this debt reduction, Huntsman has repaid in full its senior secured term loan facility under its Senior Credit Facilities.
During the full year 2017, we spent $282 million on capital expenditures compared to $318 million in 2016. We expect to spend approximately $325 million on capital expenditures in 2018.
Income Taxes
During the three months ended December 31, 2017, we recorded an income tax benefit of $14 million compared to income tax expense of $44 million during the same period in 2016. This 2017 fourth quarter income tax benefit is largely the result of the new U.S. tax law, including a revaluation of our U.S. deferred tax liabilities at a lower tax rate partially offset by transition taxes on the deemed repatriation of deferred foreign income. In the fourth quarter 2017, our adjusted effective tax rate was 23%. Our 2018 estimated adjusted effective tax rate will be approximately 21% - 23%, which includes the benefit of the recent U.S. income tax reform.
The Board Approved a 30% Dividend Increase and Share Repurchases of up to $450 Million
Effective February 7, 2018, our Board of Directors approved an increase in our quarterly per share dividend from $0.125 to $0.1625. In addition, it authorized our Company to repurchase up to $400 million in shares of our common stock in addition to the $50 million remaining under our September 2015 share repurchase authorization. Repurchases may be made through the open market or in privately negotiated transactions, and repurchases may be commenced or suspended from time to time without prior notice. Shares of common stock acquired through the repurchase program are to be held in treasury at cost.
Earnings Conference Call Information
We will hold a conference call to discuss our fourth quarter 2017 financial results on Friday, February 23, 2018 at 10:00 a.m. ET.
Call-in numbers for the conference call: |
||
U.S. participants |
(888) 680 - 0890 |
|
International participants |
(617) 213 - 4857 |
|
Passcode |
299 322 06# |
In order to facilitate the registration process, you may use the following link to pre-register for the conference call. Callers who pre-register will be given a unique PIN to gain immediate access to the call and bypass the live operator. You may pre-register at any time, including up to and after the call start time. To pre-register, please go to:
https://www.theconferencingservice.com/prereg/key.process?key=PX4DVDQR7
Webcast Information
The conference call will be available via webcast and can be accessed from the company's website at ir.huntsman.com.
Replay Information
The conference call will be available for replay beginning February 23, 2018 and ending March 2, 2018.
Call-in numbers for the replay: |
||
U.S. participants |
(888) 286 - 8010 |
|
International participants |
(617) 801 - 6888 |
|
Replay code |
29385180 |
Upcoming Conferences
During the first quarter a member of management is expected to present at the Alembic Industrial and Chemical Conference on March 1-2, 2018. A webcast of the presentation, if applicable, along with accompanying materials will be available at ir.huntsman.com.
2018 Investor Day
Huntsman will host a meeting for investors and analysts on Wednesday, May 23, 2018 from 8:00 a.m. to 12:00 p.m., local time in New York City. The agenda for the meeting will include a review of the company's business strategy and an in-depth discussion of each of the company's businesses. Presenters will include Peter Huntsman, Chairman and CEO, and other business leaders. A live webcast and presentation materials will be available the day of the event at ir.huntsman.com. A replay of the webcast will be available following the presentations. Registration information will be forthcoming.
Table 1 -- Results of Operations |
||||||||
Three months ended |
Twelve months ended |
|||||||
December 31, |
December 31, |
|||||||
In millions, except per share amounts |
2017 |
2016 |
2017 |
2016 |
||||
Revenues |
$2,203 |
$1,904 |
$8,358 |
$7,518 |
||||
Cost of goods sold |
1,694 |
1,548 |
6,546 |
5,992 |
||||
Gross profit |
509 |
356 |
1,812 |
1,526 |
||||
Operating expenses |
236 |
140 |
913 |
804 |
||||
Restructuring, impairment and plant closing costs (credits) |
7 |
(9) |
20 |
47 |
||||
Expenses associated with the merger |
10 |
- |
28 |
- |
||||
Operating income |
256 |
225 |
851 |
675 |
||||
Interest expense |
(31) |
(50) |
(165) |
(203) |
||||
Equity in income of investment in unconsolidated affiliates |
9 |
1 |
13 |
5 |
||||
Loss on early extinguishment of debt |
(18) |
- |
(54) |
(3) |
||||
Other income |
- |
1 |
2 |
- |
||||
Income before income taxes |
216 |
177 |
647 |
474 |
||||
Income tax benefit (expense) |
14 |
(44) |
(64) |
(109) |
||||
Income from continuing operations |
230 |
133 |
583 |
365 |
||||
Income (loss) from discontinued operations, net of tax(4) |
57 |
4 |
158 |
(8) |
||||
Net income |
287 |
137 |
741 |
357 |
||||
Net income attributable to noncontrolling interests, net of tax |
(41) |
(9) |
(105) |
(31) |
||||
Net income attributable to Huntsman Corporation |
$ 246 |
$ 128 |
$ 636 |
$ 326 |
||||
Adjusted EBITDA(1) |
$ 360 |
$ 210 |
$1,259 |
$ 997 |
||||
Adjusted net income(1) |
$ 186 |
$ 50 |
$ 604 |
$ 352 |
||||
Basic income per share |
$ 1.03 |
$ 0.54 |
$ 2.67 |
$ 1.38 |
||||
Diluted income per share |
$ 1.00 |
$ 0.53 |
$ 2.61 |
$ 1.36 |
||||
Adjusted diluted income per share(1) |
$ 0.76 |
$ 0.21 |
$ 2.48 |
$ 1.47 |
||||
Common share information: |
||||||||
Basic shares outstanding |
240 |
236 |
238 |
236 |
||||
Diluted shares |
245 |
241 |
244 |
240 |
||||
Diluted shares for adjusted diluted income per share |
245 |
241 |
244 |
240 |
||||
See end of press release for footnote explanations |
Table 2 -- Results of Operations by Segment |
||||||||||||
Three months ended |
Twelve months ended |
|||||||||||
December 31, |
Better / |
December 31, |
Better / |
|||||||||
In millions |
2017 |
2016 |
(Worse) |
2017 |
2016 |
(Worse) |
||||||
Segment Revenues: |
||||||||||||
Polyurethanes |
$1,227 |
$ 964 |
27% |
$4,399 |
$3,667 |
20% |
||||||
Performance Products |
514 |
515 |
0% |
2,109 |
2,126 |
(1)% |
||||||
Performance Products, pro forma(2) |
514 |
452 |
14% |
2,109 |
1,885 |
12% |
||||||
Advanced Materials |
258 |
246 |
5% |
1,040 |
1,020 |
2% |
||||||
Textile Effects |
190 |
184 |
3% |
776 |
751 |
3% |
||||||
Corporate and eliminations |
14 |
(5) |
n/m |
34 |
(46) |
n/m |
||||||
Total |
$2,203 |
$1,904 |
16% |
$8,358 |
$7,518 |
11% |
||||||
Total, pro forma(2) |
$2,203 |
$1,841 |
20% |
$8,358 |
$7,277 |
15% |
||||||
Segment Adjusted EBITDA(1): |
||||||||||||
Polyurethanes |
$ 294 |
$ 130 |
126% |
$ 850 |
$ 569 |
49% |
||||||
Performance Products |
47 |
68 |
(31)% |
296 |
316 |
(6)% |
||||||
Performance Products, pro forma(2) |
47 |
62 |
(24)% |
296 |
288 |
3% |
||||||
Advanced Materials |
53 |
50 |
6% |
219 |
223 |
(2)% |
||||||
Textile Effects |
19 |
14 |
36% |
83 |
73 |
14% |
||||||
Corporate, LIFO and other |
(53) |
(52) |
(2)% |
(189) |
(184) |
(3)% |
||||||
Total |
$ 360 |
$ 210 |
71% |
$1,259 |
$ 997 |
26% |
||||||
Total, pro forma(2) |
$ 360 |
$ 204 |
76% |
$1,259 |
$ 969 |
30% |
||||||
n/m = not meaningful |
||||||||||||
See end of press release for footnote explanations |
Table 3 -- Factors Impacting Sales Revenue |
|||||||||||
Three months ended |
|||||||||||
December 31, 2017 vs. 2016 |
|||||||||||
Average Selling Price(a) |
|||||||||||
Local |
Exchange |
Sales Mix |
Sales |
||||||||
Currency |
Rate |
& Other |
Volume(b) |
Total |
|||||||
Polyurethanes |
21% |
4% |
4% |
(2)% |
27% |
||||||
Polyurethanes, adj |
20% |
4% |
6% |
(7)% |
23% |
(e) |
|||||
Performance Products |
8% |
2% |
6% |
(16)% |
0% |
||||||
Performance Products, adj |
3% |
2% |
1% |
14% |
20% |
(c)(e) |
|||||
Advanced Materials |
2% |
3% |
1% |
(1)% |
5% |
||||||
Textile Effects |
(2)% |
2% |
(1)% |
4% |
3% |
||||||
Total Company |
13% |
3% |
7% |
(7)% |
16% |
||||||
Total Company, adj |
11% |
3% |
5% |
0% |
19% |
(c)(e) |
|||||
Twelve months ended |
|||||||||||
December 31, 2017 vs. 2016 |
|||||||||||
Average Selling Price(a) |
|||||||||||
Local |
Exchange |
Sales Mix |
Sales |
||||||||
Currency |
Rate |
& Other |
Volume(b) |
Total |
|||||||
Polyurethanes |
18% |
1% |
3% |
(2)% |
20% |
||||||
Polyurethanes, adj |
19% |
1% |
2% |
(1)% |
21% |
(d)(e) |
|||||
Performance Products |
7% |
0% |
3% |
(11)% |
(1)% |
||||||
Performance Products, adj |
3% |
0% |
1% |
13% |
17% |
(c)(d)(e) |
|||||
Advanced Materials |
1% |
1% |
0% |
0% |
2% |
||||||
Textile Effects |
(2)% |
0% |
(2)% |
7% |
3% |
||||||
Total Company |
12% |
0% |
4% |
(5)% |
11% |
||||||
Total Company, adj |
11% |
0% |
2% |
4% |
17% |
(c)(d)(e) |
|||||
(a) |
Excludes sales from tolling arrangements, by-products and raw materials. |
(b) |
Excludes sales from by-products and raw materials. |
(c) |
Pro forma adjusted to exclude the sale of the European differentiated surfactants on December 30, 2016. |
(d) |
Pro forma adjusted to exclude the impact from Hurricane Harvey in 3Q17 |
(e) |
Pro forma adjusted to exclude the impact of cetain planned maintenance outages and unplanned weather related and other outages in 2016 & 2017 |
Table 4 -- Reconciliation of U.S. GAAP to Non-GAAP Measures |
|||||||||||||||||
Income Tax |
Diluted Income |
||||||||||||||||
EBITDA |
Benefit (Expense) |
Net Income |
Per Share |
||||||||||||||
Three months ended |
Three months ended |
Three months ended |
Three months ended |
||||||||||||||
December 31, |
December 31, |
December 31, |
December 31, |
||||||||||||||
In millions, except per share amounts |
2017 |
2016 |
2017 |
2016 |
2017 |
2016 |
2017 |
2016 |
|||||||||
Net income |
$ 287 |
$ 137 |
$ 287 |
$ 137 |
$ 1.17 |
$ 0.57 |
|||||||||||
Net income attributable to noncontrolling interests |
(41) |
(9) |
(41) |
(9) |
(0.17) |
(0.04) |
|||||||||||
Net income attributable to Huntsman Corporation |
246 |
128 |
246 |
128 |
1.00 |
0.53 |
|||||||||||
Interest expense from continuing operations |
31 |
50 |
|||||||||||||||
Interest expense from discontinued operations(4) |
11 |
- |
|||||||||||||||
Income tax (benefit) expense from continuing operations |
(14) |
44 |
$ 14 |
$ (44) |
|||||||||||||
Income tax expense (benefit) from discontinued operations(4) |
26 |
(16) |
|||||||||||||||
Depreciation and amortization from continuing operations |
84 |
80 |
|||||||||||||||
Depreciation and amortization from discontinued operations(4) |
- |
30 |
|||||||||||||||
Acquisition and integration expenses |
2 |
1 |
(1) |
- |
1 |
1 |
- |
- |
|||||||||
EBITDA / Income from discontinued operations, net of tax(4) |
(94) |
(18) |
N/A |
N/A |
(57) |
(4) |
(0.23) |
(0.02) |
|||||||||
Minority interest of discontinued operations(1)(4) |
31 |
3 |
N/A |
N/A |
31 |
3 |
0.13 |
0.01 |
|||||||||
U.S. tax reform impact on minority interest |
(6) |
- |
N/A |
N/A |
(6) |
- |
(0.02) |
- |
|||||||||
U.S. tax reform impact on tax expense |
N/A |
N/A |
(52) |
- |
(52) |
- |
(0.21) |
- |
|||||||||
Gain on disposition of businesses/assets |
(1) |
(97) |
- |
13 |
(1) |
(84) |
- |
(0.35) |
|||||||||
Loss on early extinguishment of debt |
18 |
- |
(7) |
- |
11 |
- |
0.04 |
- |
|||||||||
Expenses associated with merger, net of tax |
10 |
- |
(9) |
- |
1 |
- |
- |
- |
|||||||||
Certain legal settlements and related (income) expenses |
(12) |
1 |
4 |
- |
(8) |
1 |
(0.03) |
- |
|||||||||
Net plant incident costs |
3 |
- |
(2) |
- |
1 |
- |
- |
- |
|||||||||
Amortization of pension and postretirement actuarial losses |
18 |
13 |
(5) |
(2) |
13 |
11 |
0.05 |
0.05 |
|||||||||
Restructuring, impairment and plant closing and transition costs (credits) |
7 |
(9) |
(1) |
3 |
6 |
(6) |
0.02 |
(0.02) |
|||||||||
Adjusted(1) |
$ 360 |
$ 210 |
$ (59) |
$ (30) |
$ 186 |
$ 50 |
$ 0.76 |
$ 0.21 |
|||||||||
Pro forma adjustments(2) |
- |
(6) |
|||||||||||||||
Pro forma adjusted EBITDA(1) |
$ 360 |
$ 204 |
|||||||||||||||
Adjusted income tax expense(1) |
$ 59 |
$ 30 |
|||||||||||||||
Net income attributable to noncontrolling interests, net of tax |
41 |
9 |
|||||||||||||||
Minority interest of discontinued operations(1)(4) |
(31) |
(3) |
|||||||||||||||
U.S. tax reform impact on minority interest |
6 |
- |
|||||||||||||||
Adjusted pre-tax income(1) |
$ 261 |
$ 86 |
|||||||||||||||
Adjusted effective tax rate |
23% |
35% |
|||||||||||||||
Income Tax |
Diluted Income |
||||||||||||||||
EBITDA |
Expense |
Net Income |
Per Share |
||||||||||||||
Three months ended |
Three months ended |
Three months ended |
Three months ended |
||||||||||||||
September 30, |
September 30, |
September 30, |
September 30, |
||||||||||||||
In millions, except per share amounts |
2017 |
2017 |
2017 |
2017 |
|||||||||||||
Net income |
$ 179 |
$ 179 |
$ 0.73 |
||||||||||||||
Net income attributable to noncontrolling interests |
(32) |
(32) |
(0.13) |
||||||||||||||
Net income attributable to Huntsman Corporation |
147 |
147 |
0.60 |
||||||||||||||
Interest expense from continuing operations |
39 |
||||||||||||||||
Interest expense from discontinued operations(4) |
8 |
||||||||||||||||
Income tax expense from continuing operations |
35 |
$ (35) |
|||||||||||||||
Income tax expense from discontinued operations(4) |
17 |
||||||||||||||||
Depreciation and amortization from continuing operations |
80 |
||||||||||||||||
Depreciation and amortization from discontinued operations(4) |
9 |
||||||||||||||||
Acquisition and integration expenses |
10 |
(3) |
7 |
0.03 |
|||||||||||||
EBITDA / Income from discontinued operations, net of tax(4) |
(97) |
N/A |
(63) |
(0.26) |
|||||||||||||
Minority interest of discontinued operations(1)(4) |
12 |
N/A |
12 |
0.05 |
|||||||||||||
Loss on early extinguishment of debt |
35 |
(12) |
23 |
0.09 |
|||||||||||||
Expenses associated with merger |
12 |
(1) |
11 |
0.05 |
|||||||||||||
Net plant incident costs |
13 |
(4) |
9 |
0.04 |
|||||||||||||
Amortization of pension and postretirement actuarial losses |
19 |
(3) |
16 |
0.07 |
|||||||||||||
Restructuring, impairment and plant closing and transition costs |
1 |
1 |
2 |
0.01 |
|||||||||||||
Adjusted(1) |
$ 340 |
$ (57) |
$ 164 |
$ 0.67 |
|||||||||||||
Adjusted income tax expense(1) |
$ 57 |
||||||||||||||||
Net income attributable to noncontrolling interests, net of tax |
32 |
||||||||||||||||
Minority interest of discontinued operations(1)(4) |
(12) |
||||||||||||||||
U.S. tax reform impact on minority interest |
- |
||||||||||||||||
Adjusted pre-tax income(1) |
$ 241 |
||||||||||||||||
Adjusted effective tax rate |
24% |
||||||||||||||||
Income Tax |
Diluted Income |
||||||||||||||||
EBITDA |
Expense |
Net Income |
Per Share |
||||||||||||||
Twelve months ended |
Twelve months ended |
Twelve months ended |
Twelve months ended |
||||||||||||||
December 31, |
December 31, |
December 31, |
December 31, |
||||||||||||||
In millions, except per share amounts |
2017 |
2016 |
2017 |
2016 |
2017 |
2016 |
2017 |
2016 |
|||||||||
Net income |
$ 741 |
$ 357 |
$ 741 |
$ 357 |
$ 3.04 |
$ 1.49 |
|||||||||||
Net income attributable to noncontrolling interests |
(105) |
(31) |
(105) |
(31) |
(0.43) |
(0.13) |
|||||||||||
Net income attributable to Huntsman Corporation |
636 |
326 |
636 |
326 |
2.61 |
1.36 |
|||||||||||
Interest expense from continuing operations |
165 |
203 |
|||||||||||||||
Interest expense (income) from discontinued operations(4) |
19 |
(1) |
|||||||||||||||
Income tax expense from continuing operations |
64 |
109 |
(64) |
(109) |
|||||||||||||
Income tax expense (benefit) from discontinued operations(4) |
67 |
(24) |
|||||||||||||||
Depreciation and amortization from continuing operations |
319 |
318 |
|||||||||||||||
Depreciation and amortization from discontinued operations(4) |
68 |
114 |
|||||||||||||||
Acquisition and integration expenses |
19 |
12 |
(5) |
(3) |
14 |
9 |
0.06 |
0.04 |
|||||||||
EBITDA / Income from discontinued operations, net of tax(4) |
(312) |
(81) |
N/A |
N/A |
(158) |
8 |
(0.65) |
0.03 |
|||||||||
Minority interest of discontinued operations(1)(4) |
49 |
11 |
N/A |
N/A |
49 |
11 |
0.20 |
0.05 |
|||||||||
U.S. tax reform impact on minority interest |
(6) |
- |
N/A |
N/A |
(6) |
- |
(0.02) |
- |
|||||||||
U.S. tax reform impact on tax expense |
N/A |
N/A |
(52) |
- |
(52) |
- |
(0.21) |
- |
|||||||||
Gain on disposition of businesses/assets |
(9) |
(97) |
- |
13 |
(9) |
(84) |
(0.04) |
(0.35) |
|||||||||
Loss on early extinguishment of debt |
54 |
3 |
(19) |
(1) |
35 |
2 |
0.14 |
0.01 |
|||||||||
Expenses associated with merger |
28 |
- |
(10) |
- |
18 |
- |
0.07 |
- |
|||||||||
Certain legal settlements and related (income) expenses |
(11) |
1 |
4 |
- |
(7) |
1 |
(0.03) |
- |
|||||||||
Net plant incident costs |
16 |
- |
(6) |
- |
10 |
- |
0.04 |
- |
|||||||||
Amortization of pension and postretirement actuarial losses |
73 |
55 |
(16) |
(12) |
57 |
43 |
0.23 |
0.18 |
|||||||||
Restructuring, impairment and plant closing and transition costs |
20 |
48 |
(3) |
(12) |
17 |
36 |
0.07 |
0.15 |
|||||||||
Adjusted(1) |
$ 1,259 |
$ 997 |
$ (171) |
$ (124) |
$ 604 |
$ 352 |
$ 2.48 |
$ 1.47 |
|||||||||
Pro forma adjustments(2) |
- |
(28) |
|||||||||||||||
Pro forma adjusted EBITDA(1) |
$ 1,259 |
$ 969 |
|||||||||||||||
Adjusted income tax expense(1) |
$ 171 |
$ 124 |
|||||||||||||||
Net income attributable to noncontrolling interests, net of tax |
105 |
31 |
|||||||||||||||
Minority interest of discontinued operations(1)(4) |
(49) |
(11) |
|||||||||||||||
U.S. tax reform impact on minority interest |
6 |
- |
|||||||||||||||
Adjusted pre-tax income(1) |
$ 837 |
$ 496 |
|||||||||||||||
Adjusted effective tax rate |
20% |
25% |
|||||||||||||||
See end of press release for footnote explanations |
Table 5 -- Selected Balance Sheet Items |
||||||
December 31, |
September 30, |
December 31, |
||||
In millions |
2017 |
2017 |
2016 |
|||
Cash |
$ 481 |
$ 451 |
$ 396 |
|||
Accounts and notes receivable, net |
1,283 |
1,247 |
1,183 |
|||
Inventories |
1,073 |
1,084 |
918 |
|||
Other current assets |
262 |
240 |
281 |
|||
Current assets held for sale |
2,880 |
2,745 |
777 |
|||
Property, plant and equipment, net |
3,098 |
3,035 |
3,034 |
|||
Other assets |
1,167 |
1,181 |
1,137 |
|||
Noncurrent assets held for sale |
- |
- |
1,463 |
|||
Total assets |
$ 10,244 |
$ 9,983 |
$ 9,189 |
|||
Accounts payable |
$ 964 |
$ 891 |
$ 790 |
|||
Other current liabilities |
569 |
537 |
471 |
|||
Current portion of debt |
40 |
29 |
50 |
|||
Current liabilities held for sale |
1,692 |
1,633 |
467 |
|||
Long-term debt |
2,258 |
2,845 |
4,122 |
|||
Other liabilities |
1,350 |
1,457 |
1,429 |
|||
Noncurrent liabilities held for sale |
- |
- |
393 |
|||
Total equity |
3,371 |
2,591 |
1,467 |
|||
Total liabilities and equity |
$ 10,244 |
$ 9,983 |
$ 9,189 |
|||
Table 6 -- Outstanding Debt |
||||
December 31, |
December 31, |
|||
In millions |
2017 |
2016 |
||
Debt: |
||||
Senior credit facilities |
$ - |
$ 1,967 |
||
Accounts receivable programs |
180 |
208 |
||
Senior notes |
1,927 |
1,812 |
||
Variable interest entities |
107 |
126 |
||
Other debt |
84 |
59 |
||
Total debt - excluding affiliates |
2,298 |
4,172 |
||
Total cash |
481 |
396 |
||
Net debt- excluding affiliates |
$ 1,817 |
$ 3,776 |
Table 7 -- Summarized Statement of Cash Flows |
||||||||
Three months ended |
Twelve months ended |
|||||||
December 31, |
December 31, |
|||||||
In millions |
2017 |
2016 |
2017 |
2016 |
||||
Total cash at beginning of period(a) |
$ 637 |
$450 |
$ 425 |
$ 269 |
||||
Net cash provided by operating activities - continuing operations |
304 |
238 |
842 |
974 |
||||
Net cash provided by operating activities - discontinued operations(4) |
172 |
2 |
377 |
114 |
||||
Net cash (used in) provided by investing activities - continuing operations |
(120) |
94 |
(265) |
(119) |
||||
Net cash used in investing activities - discontinued operations(4) |
(110) |
(26) |
(159) |
(83) |
||||
Net cash used in financing activities |
(170) |
(326) |
(519) |
(723) |
||||
Effect of exchange rate changes on cash |
6 |
(7) |
18 |
(6) |
||||
Change in restricted cash |
- |
- |
- |
(1) |
||||
- |
||||||||
Total cash at end of period(a) |
$ 719 |
$425 |
$ 719 |
$ 425 |
||||
Supplemental cash flow information - continuing operations: |
||||||||
Cash paid for interest |
$ (47) |
$ (66) |
$ (169) |
$(205) |
||||
Cash paid for income taxes |
(45) |
(11) |
(9) |
(40) |
||||
Cash paid for capital expenditures |
(123) |
(104) |
(282) |
(318) |
||||
Depreciation and amortization |
84 |
80 |
319 |
318 |
||||
- |
||||||||
Changes in primary working capital: |
||||||||
Accounts and notes receivable |
(35) |
(22) |
(183) |
(25) |
||||
Inventories |
14 |
44 |
(104) |
177 |
||||
Accounts payable |
59 |
57 |
154 |
46 |
||||
Total cash provided by (used in) primary working capital |
$ 38 |
$ 79 |
$ (133) |
$ 198 |
||||
Three months ended |
Twelve months ended |
|||||||
December 31, |
December 31, |
|||||||
2017 |
2016 |
2017 |
2016 |
|||||
Free cash flow(3): |
||||||||
Net cash provided by operating activities |
$ 304 |
$238 |
$ 842 |
$ 974 |
||||
Capital expenditures |
(123) |
(104) |
(282) |
(318) |
||||
All other investing activities, excluding acquisition and disposition activities(b) |
(1) |
(1) |
6 |
- |
||||
Non-recurring merger costs(c) |
10 |
- |
28 |
- |
||||
Total free cash flow |
$ 190 |
$133 |
$ 594 |
$ 656 |
||||
Adjusted EBITDA |
$ 360 |
$210 |
$ 1,259 |
$ 997 |
||||
Capital expenditures |
(123) |
(104) |
(282) |
(318) |
||||
Capital reimbursements |
2 |
4 |
3 |
32 |
||||
Interest |
(47) |
(66) |
(169) |
(205) |
||||
Income taxes |
(45) |
(11) |
(9) |
(40) |
||||
Primary working capital change |
38 |
79 |
(133) |
198 |
||||
Restructuring |
(10) |
(4) |
(36) |
(46) |
||||
Pensions |
(26) |
(15) |
(111) |
(60) |
||||
Maintenance & other |
41 |
40 |
72 |
98 |
||||
Total free cash flow(3) |
$ 190 |
$133 |
$ 594 |
$ 656 |
||||
(a) |
Includes restricted cash and cash held in discontinued operations. |
|
(b) |
Represents "Acquisition of business, net of cash acquired", "Cash received from purchase price adjustment for business acquired", and "Proceeds from sale of business/assets". |
|
(c) |
Represents payments associated with one-time costs of the terminated merger of equals with Clariant. |
Footnotes |
|
(1) |
We use adjusted EBITDA to measure the operating performance of our business and for planning and evaluating the performance of our business segments. We provide adjusted net income because we feel it provides meaningful insight for the investment community into the performance of our business. We believe that net income (loss) is the performance measure calculated and presented in accordance with generally accepted accounting principles in the U.S. ("GAAP") that is most directly comparable to adjusted EBITDA and adjusted net income. Additional information with respect to our use of each of these financial measures follows: |
Adjusted EBITDA, adjusted net income (loss) and adjusted diluted income (loss) per share, as used herein, are not necessarily comparable to other similarly titled measures of other companies. |
|
Adjusted EBITDA is computed by eliminating the following from net income (loss): (a) net income attributable to noncontrolling interest, net of tax; (b) interest; (c) income taxes; (d) depreciation and amortization; (e) acquisition and integration expenses; (f) EBITDA from discontinued operations; (g) minority interest of discontinued operations; (h) U.S. tax reform impact on minority interest; (i) loss (gain) on disposition of businesses/assets; (j) loss on early extinguishment of debt; (k) expenses associated with merger, net of tax; (l) certain legal settlements and related (income) expenses; (m) net plant incident costs; (n) amortization of pension and postretirement actuarial losses (gains) and; (p) restructuring, impairment and plant closing costs (credits). The reconciliation of adjusted EBITDA to net income (loss) is set forth in Table 4 above. |
|
Adjusted net income (loss) and adjusted diluted income (loss) per share are computed by eliminating the after tax impact of the following items from net income (loss): (a) net income attributable to noncontrolling interest; (b) acquisition and integration expenses; (c) loss (income) from discontinued operations; (d) minority interest of discontinued operations; (e) U.S. tax reform impact on minority interest; (f) U.S. tax reform impact on tax expense; (g) loss (gain) on disposition of businesses/assets; (h) loss on early extinguishment of debt; (i) expenses associated with merger, net of tax; (j) certain legal settlements and related (income) expenses; (k) net plant incident costs; (l) amortization of pension and postretirement actuarial losses (gains); and (m) restructuring, impairment and plant closing costs (credits). The income tax impacts, if any, of each adjusting item represent a ratable allocation of the total difference between the unadjusted tax expense and the total adjusted tax expense, computed without consideration of any adjusting items using a with and without approach. We do not adjust for changes in tax valuation allowances because we do not believe it provides more meaningful information than is provided under GAAP. The reconciliation of adjusted net income (loss) to net income (loss) is set forth in Table 4 above. |
|
(2) |
Pro forma adjusted to exclude the sale of our European differentiated surfactants business to Innospec on December 30, 2016 as if it had occurred at the beginning of the relevant period. |
(3) |
Management internally uses a free cash flow measure: (a) to evaluate the Company's liquidity, (b) to evaluate strategic investments, (c) to plan stock buyback and dividend levels and (d) to evaluate the Company's ability to incur and service debt. Free cash flow is not a defined term under U.S. GAAP, and it should not be inferred that the entire free cash flow amount is available for discretionary expenditures. The Company defines free cash flow as cash flow provided by operating activities less cash flow used in investing activities, excluding acquisition/disposition activities and non-recurring separation costs. Free cash flow is typically derived directly from the Company's condensed consolidated statement of cash flows; however, it may be adjusted for items that affect comparability between periods. |
(4) |
During the third quarter of 2017 we separated our Pigments and Additives division through an Initial Public Offering of Venator Materials PLC; Additionally, during the first quarter 2010 we closed our Australian styrenics operations. Results from these associated businesses are treated as discontinued operations. |
About Huntsman:
Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated and specialty chemicals with 2017 revenues of approximately $8 billion. Our chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. We operate more than 75 manufacturing, R&D and operations facilities in approximately 30 countries and employ approximately 10,000 associates within our four distinct business divisions. For more information about Huntsman, please visit the company's website at www.huntsman.com.
Social Media:
Twitter: www.twitter.com/Huntsman_Corp
Facebook: www.facebook.com/huntsmancorp
LinkedIn: www.linkedin.com/company/huntsman
Forward-Looking Statements:
Statements in this release that are not historical are forward-looking statements. These statements are based on management's current beliefs and expectations. The forward-looking statements in this release are subject to uncertainty and changes in circumstances and involve risks and uncertainties that may affect the company's operations, markets, products, services, prices and other factors as discussed in the Huntsman companies' filings with the U.S. Securities and Exchange Commission. Significant risks and uncertainties may relate to, but are not limited to, volatile global economic conditions, cyclical and volatile product markets, disruptions in production at manufacturing facilities, reorganization or restructuring of Huntsman's operations, the ability to implement cost reductions and manufacturing optimization improvements in Huntsman businesses, and other financial, economic, competitive, environmental, political, legal, regulatory and technological factors. The company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by applicable laws.
View original content with multimedia:http://www.prnewswire.com/news-releases/huntsman-announces-strong-fourth-quarter-2017-results-net-leverage-reduced-to-14x-the-board-approves-a-30-dividend-increase-and-share-repurchases-of-up-to-450-million-300603217.html
SOURCE Huntsman Corporation
Released February 23, 2018